Modulation of SLP-2 expression protects against alpha-synuclein neuropathology by mitigating mitochondrial dysfunction
Cyril Bolduc, Maria Paulina Castelo Rueda, Marina Lorente Picón…·Martin Lévesque
This study shows that increasing SLP-2 levels reduces alpha-synuclein-induced mitochondrial damage and neurodegeneration in Parkinson's disease models.